At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 75 enrolled
Drug / intervention
Luliconazole Cream 1% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis
In Brief
A Phase 4 clinical trial evaluating Luliconazole Cream 1% and Vehicle Cream for Tinea Corporis. Completed, enrolled 75 participants across 3 sites in 2 countries.
Detailed Summary
The objective of this study was to evaluate the safety, efficacy, and pharmacokinetics of luliconazole cream 1% when applied topically for 7 days in pediatric participants 2 years to 17 years of age (inclusive) with tinea corporis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinea Corporis
CountriesDominican Republic, Honduras
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedMay 2016
Primary CompletionJun 2016
Study CompletionSep 2016
TodayJul 2026
First PostedMay 11, 2016
Enrollment StartFeb 8, 2016
Primary CompletionJun 29, 2016
Study CompletionSep 22, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.1 years ago
Interventions
Luliconazole Cream 1%drug
Luliconazole cream will be applied per schedule specified in the arm.
Vehicle Creamdrug
Vehicle cream will be applied per schedule specified in the arm.